Abdurrahman Hasymi
Departemen Histologi, Fakultas Kedokteran, Universitas Alkhairaat

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Analisis Reaksi Obat Tidak Diinginkan Yang Terkait Dengan Interaksi Obat Pada Pasien Yang Dirawat Dengan Amlodipin Amelia Rumi; Andi Atirah Masyita; Muhammad Rinaldhi Tandah; Inggrid Alvionita H. Lagoa; Abdurrahman Hasymi; Ratih Pratiwi Sari
BORNEO JOURNAL OF PHARMASCIENTECH Vol 10 No 2 (2026): Borneo Journal Of Pharmascientech
Publisher : Universitas Borneo Lestari

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59053/bjp.v10i2.830

Abstract

Drug interactions may cause adverse drug reactions (ADRs), particularly in patients with hypertension and comorbidities who receive multiple medications concomitantly. This study aimed to identify suspected ADRs associated with drug interactions in patients receiving amlodipine and to assess causality using the Naranjo Algorithm. This was a descriptive study with a cross-sectional design and a prospective approach conducted among patients with hypertension at a hospital in Palu, Indonesia, from October to December 2023. Data were collected through patient interviews and medical record reviews, analyzed descriptively, and assessed using the Naranjo Algorithm. Among the 50 patients studied, four (8%) experienced suspected ADRs associated with the concomitant use of amlodipine and other medications. Three of the 39 patients receiving simvastatin (7.69%) reported muscle pain and weakness, whereas one of the eight patients receiving metformin (12.50%) experienced hypoglycemia, with a random blood glucose level of 37 mg/dL. The Naranjo Algorithm yielded a score of +5 for the cases involving simvastatin and +6 for the case involving metformin, both of which were classified as probable. These findings highlight the importance of clinical monitoring and medication review in patients receiving amlodipine concomitantly with other medications. However, the causal relationship between the drug interactions and the observed clinical manifestations should be interpreted cautiously.